Improved visibility of brain tumors in synthetic MP‐RAGE anatomies with pure T1 weighting

Conventional MRI for brain tumor diagnosis employs T2‐weighted and contrast‐enhanced T1‐weighted sequences. Non‐enhanced T1‐weighted images provide improved anatomical details for precise tumor location, but reduced tumor‐to‐background contrast as elevated T1 and proton density (PD) values in tumor tissue affect the signal inversely. Radiofrequency (RF) coil inhomogeneities may further mask tumor and edema outlines. To overcome this problem, the aims of this work were to employ quantitative MRI techniques to create purely T1‐weighted synthetic anatomies which can be expected to yield improved tissue and tumor‐to‐background contrasts, to compare the quality of conventional and synthetic anatomies, and to investigate optical contrast and visibility of brain tumors and edema in synthetic anatomies. Conventional magnetization‐prepared rapid acquisition of gradient echoes (MP‐RAGE) anatomies and maps of T1, PD and RF coil profiles were acquired in comparable and clinically feasible times. Three synthetic MP‐RAGE anatomies (PD T1 weighting both with and without RF bias; pure T1 weighting) were calculated for healthy subjects and 32 patients with brain tumors. In healthy subjects, the PD T1‐weighted synthetic anatomies with RF bias precisely matched the conventional anatomies, yielding high signal‐to‐noise (SNR) and contrast‐to‐noise (CNR) ratios. Pure T1 weighting yielded lower SNR, but high CNR, because of increased optical contrasts. In patients with brain tumors, synthetic anatomies with pure T1 weighting yielded significant increases in optical contrast and improved visibility of tumor and edema in comparison with anatomies reflecting conventional T1 contrasts. In summary, the optimized purely T1‐weighted synthetic anatomy with an isotropic resolution of 1 mm, as proposed in this work, considerably enhances optical contrast and visibility of brain tumors and edema. Copyright © 2015 John Wiley & Sons, Ltd.

[1]  P P Fatouros,et al.  In Vivo Brain Water Determination by T1 Measurements: Effect of Total Water Content, Hydration Fraction, and Field Strength , 1991, Magnetic resonance in medicine.

[2]  Albert Lai,et al.  Time course of imaging changes of GBM during extended bevacizumab treatment , 2008, Journal of Neuro-Oncology.

[3]  Ralf Deichmann,et al.  Within‐lesion differences in quantitative MRI parameters predict contrast enhancement in multiple sclerosis , 2013, Journal of magnetic resonance imaging : JMRI.

[4]  Alina Jurcoane,et al.  Quantitative T2 mapping of recurrent glioblastoma under bevacizumab improves monitoring for non-enhancing tumor progression and predicts overall survival. , 2013, Neuro-oncology.

[5]  Christine Preibisch,et al.  MR-based hypoxia measures in human glioma , 2013, Journal of Neuro-Oncology.

[6]  J. Smirniotopoulos,et al.  Glioblastoma multiforme: radiologic-pathologic correlation. , 1996, Radiographics : a review publication of the Radiological Society of North America, Inc.

[7]  J. Mugler,et al.  Three‐dimensional magnetization‐prepared rapid gradient‐echo imaging (3D MP RAGE) , 1990, Magnetic resonance in medicine.

[8]  M Hoehn-Berlage,et al.  Quantitative magnetic resonance imaging of rat brain tumors: in vivo NMR relaxometry for the discrimination of normal and pathological tissues. , 1994, Technology and health care : official journal of the European Society for Engineering and Medicine.

[9]  R Deichmann,et al.  Quantification of T1 values by SNAPSHOT-FLASH NMR imaging , 1992 .

[10]  N. Sakai,et al.  Correlation between magnetic resonance imaging and histopathology of intracranial glioma. , 1991, Neurological research.

[11]  Terry M Peters,et al.  Synthetic T1-weighted brain image generation with incorporated coil intensity correction using DESPOT1. , 2006, Magnetic resonance imaging.

[12]  Steen Moeller,et al.  T 1 weighted brain images at 7 Tesla unbiased for Proton Density, T 2 ⁎ contrast and RF coil receive B 1 sensitivity with simultaneous vessel visualization , 2009, NeuroImage.

[13]  R. Deichmann,et al.  Influence of RF spoiling on the stability and accuracy of T1 mapping based on spoiled FLASH with varying flip angles , 2009, Magnetic resonance in medicine.

[14]  R Turner,et al.  Optimisation of the 3D MDEFT sequence for anatomical brain imaging: technical implications at 1.5 and 3 T , 2004, NeuroImage.

[15]  R. Kurland,et al.  Magnetic resonance of brain tumors: considerations of imaging contrast on the basis of relaxation measurements. , 1985, Magnetic resonance imaging.

[16]  N Jon Shah,et al.  MP‐SAGE: A new MP‐RAGE sequence with enhanced SNR and CNR for brain imaging utilizing square‐spiral phase encoding and variable flip angles , 2006, Magnetic resonance in medicine.

[17]  D. Louis Collins,et al.  Sensitivity of voxel-based morphometry analysis to choice of imaging protocol at 3 T , 2009, NeuroImage.

[18]  B A Kall,et al.  Imaging-based stereotaxic serial biopsies in untreated intracranial glial neoplasms. , 1987, Journal of neurosurgery.

[19]  Albert Lai,et al.  Quantification of edema reduction using differential quantitative T2 (DQT2) relaxometry mapping in recurrent glioblastoma treated with bevacizumab , 2011, Journal of Neuro-Oncology.

[20]  E. Hattingen,et al.  Bevacizumab impairs oxidative energy metabolism and shows antitumoral effects in recurrent glioblastomas: a 31P/1H MRSI and quantitative magnetic resonance imaging study. , 2011, Neuro-oncology.

[21]  Tumours of the Central Nervous System , 1975 .

[22]  Ralf Deichmann,et al.  A fast B1-mapping method for the correction and normalization of magnetization transfer ratio maps at 3 T , 2010, NeuroImage.

[23]  A. Marmarou,et al.  Use of magnetic resonance imaging for in vivo measurements of water content in human brain: method and normal values. , 1999, Journal of neurosurgery.

[24]  Ralf Deichmann,et al.  Quantitative proton density mapping: correcting the receiver sensitivity bias via pseudo proton densities , 2012, NeuroImage.

[25]  M. Tovi,et al.  MR imaging in cerebral gliomas analysis of tumour tissue components. , 1993, Acta radiologica. Supplementum.

[26]  J N Lee,et al.  Improved precision in calculated T1 MR images using multiple spin-echo acquisition. , 1986, Journal of computer assisted tomography.

[27]  Benjamin M Ellingson,et al.  Recurrent glioblastoma treated with bevacizumab: contrast-enhanced T1-weighted subtraction maps improve tumor delineation and aid prediction of survival in a multicenter clinical trial. , 2014, Radiology.

[28]  M. Westphal,et al.  Signal intensity in T2’ magnetic resonance imaging is related to brain glioma grade , 2011, European Radiology.

[29]  Reto Meuli,et al.  MP2RAGE Multiple Sclerosis Magnetic Resonance Imaging at 3 T , 2012, Investigative radiology.

[30]  R. Deichmann,et al.  T1 mapping using spoiled FLASH‐EPI hybrid sequences and varying flip angles , 2009, Magnetic resonance in medicine.

[31]  E M Haacke,et al.  Accurate determination of spin‐density and T1 in the presence of RF‐field inhomogeneities and flip‐angle miscalibration , 1998, Magnetic resonance in medicine.

[32]  J Debus,et al.  Fast fluid‐attenuated inversion‐recovery (FLAIR) MRI in the assessment of intraaxial brain tumors , 1998, Journal of magnetic resonance imaging : JMRI.

[33]  R. Tanaka,et al.  Magnetic resonance imaging and histopathology of cerebral gliomas , 2004, Neuroradiology.

[34]  Nikolaus Weiskopf,et al.  Unified segmentation based correction of R1 brain maps for RF transmit field inhomogeneities (UNICORT) , 2011, NeuroImage.

[35]  Joseph V. Hajnal,et al.  High Signal Regions in Normal White Matter Shown by Heavily T2‐Weighted CSF Nulled IR Sequences , 1992, Journal of computer assisted tomography.

[36]  Tobias Kober,et al.  MP2RAGE, a self bias-field corrected sequence for improved segmentation and T1-mapping at high field , 2010, NeuroImage.

[37]  W. Nitz,et al.  MP RAGE: a three-dimensional, T1-weighted, gradient-echo sequence--initial experience in the brain. , 1992, Radiology.

[38]  R. Turner,et al.  Optimization of 3-D MP-RAGE Sequences for Structural Brain Imaging , 2000, NeuroImage.

[39]  M. Thelen,et al.  Tissue characterization with T1, T2, and proton density values: results in 160 patients with brain tumors. , 1988, Radiology.

[40]  Nadim Joni Shah,et al.  A new method for fast quantitative mapping of absolute water content in vivo , 2006, NeuroImage.

[41]  R. Deichmann,et al.  Correction of systematic errors in quantitative proton density mapping , 2012, Magnetic resonance in medicine.